Following the "Accelerating Innovation in the Bioscience Revolution" retreat in Lake Tahoe, an Advisory Committee has been formed to push forward the many valuable ideas presented at the retreat. These include developing more specific medical research policy recommendations and exploring collaboration opportunities. This committee includes leaders from the pharmaceutical, biotech, regulatory, funding, biomedical research and patient advocacy communities.

This planning meeting brings together members of the Advisory Board for the "Celebration of Science," a series of events to take place September 7—9. This effort aims to elevate bioscience research to its deserved position as a top national priority and encourage both public and private commitments to supporting this crucial work. Advisory board members include leaders in the field from government, academia, patient groups and the private sector.

This annual charity event benefits FasterCures, the Milken Institute's Center for Accelerating Medical Solutions. Think of it as a Goodwill Games for gourmands, a World Cup for foodies. Team up with celebrities and compete against leaders in business, entertainment and government during a fun-filled evening of great food and wine, all while lending your support to a vitally important cause. For more information, visit www.globalgourmetgames.org.

Moderator:
Michael Milken, Chairman, Milken Institute

Never has the promise of medical science appeared greater. A new era of personalized medicine seems to be at hand, promising longevity and improved quality of life. But realizing it is proving to be tougher and taking longer than expected. Progress has bogged down in the face of financing, regulatory and structural hurdles. With lives hanging in the balance, how can we create a more vibrant innovation ecosystem to shake up the status quo in medical science? What innovative models already exist in different disease research areas? How do we overcome a culture of risk aversion? How does the business model need to change? How can we direct more resources into prevention and early diagnosis rather than treating disease after the fact? This panel will discuss what it takes to push ideas forward and make change happen.

Moderator:
Willow Bay, Special Correspondent, Bloomberg Television; Senior Editor, Huffington Post

Water scarcity is poised to become the next explosive issue of our time. It's the world's most essential - and most threatened - finite resource. From the American Southwest to sub-Saharan Africa to the Middle East, people are working to find solutions and forge compromises to ensure that water continues to flow. This timely conversation will examine opportunities for investment and the role of nonprofits and corporations in heading off a crisis, with the latest updates from experts in the field. Everything is fair game in this critical, solutions-oriented panel, including new technologies for storage, treatment and efficiency; aging infrastructure; the increasing demand for recycled water; and the impact of climate change and population growth.

Moderator:
Cecilia Arradaza, Director, Communications and Marketing, FasterCures

Mobile technologies and social media are changing the world in many ways, but to what extent are they being used to improve health? There will be 1.4 billion people with smartphones worldwide by 2015, and 500 million of them will be using mobile health applications. From fitness games on the Wii or Xbox Kinect to diabetes monitoring devices that upload data through your iPhone to a "blue button" that allows you to download a copy of your medical records - the tools are coming fast and furious. What will the future of mobile and networked health look like? Are you concerned about having your personal health information in the cloud? What could we do with all the data being generated if we put it all together?

Moderator:
Paul Irving, Senior Managing Director and Chief Operating Officer, Milken Institute

How will boomers reinvent themselves - and upend the very concept of retirement - in their next stage of life? In this session, we're joined by an exceptional group of second-act success stories. Each of our panelists was accomplished and visible in his or her principal career, and each is now engaged in a whole new chapter of fulfilling and high-impact work driven by a passion to do good. Through their personal narratives, our panelists are spreading the message that helping others as we age is the ultimate encore career opportunity.

Moderator:
Melissa Stevens, Deputy Executive Director, FasterCures / The Center for Accelerating Medical Solutions

Translational research - the point at which general scientific knowledge starts to be applied to addressing a specific disease or condition - is the first step on the path to developing a new drug. But traditional investors in translational research (large- and medium-cap biopharmaceutical companies and life science-focused venture capital funds) are becoming increasingly risk averse in the face of escalating challenges in the drug development process. FasterCures recently hosted a Financial Innovations Lab to examine business models and financial instruments that can improve the risk/return ratio for early-stage investors. In this session you'll hear from experts who have designed and implemented new models like leveraged funds, research-based obligations and collaborative funding. If we can find a way to close the funding gap for translational research, we can get one step closer to urgently needed treatments.

Moderator:
Margaret Anderson, Executive Director, FasterCures / The Center for Accelerating Medical Solutions

Emerging and frontier nations represent huge untapped markets. Given how quickly these economies are growing and the size of the potential consumer base, the right innovations have the potential to deliver huge returns and exponential industry growth, especially in the areas of energy, agriculture and health. Envision the possibilities if emerging nations adopt renewable transportation fuels on a broad scale, or if businesses in growing megacities finally have reliable and affordable electricity. Look at what mobile technology is already doing for communications, health, banking and commerce in remote areas, and imagine what its continued evolution could bring. Visualize the societal benefits and productivity gains that emerging markets could achieve with breakthroughs in malaria and TB diagnosis and treatment. Picture innovations in agriculture that double crop yields to feed growing populations. This panel will look at specific market and investment opportunities in the emerging world - as well as the exciting possibilities for new technologies to improve millions of lives.

Moderator:
Sharon Begley, Senior Health & Science Correspondent, Reuters

The obesity epidemic is taking a huge toll in the United States, but it's not a uniquely American problem. From industrialized nations like Great Britain and Germany to emerging economies like Egypt, Mexico and China, populations are growing steadily more overweight. This dangerous trend has serious implications for public health, productivity, human capital formation and economic development. What are the factors driving these numbers? Which nations seem able to maintain healthier populations, and why? What role has the global food industry played in this trend - and can it be part of the solution? What can employers do? How can government and business offer smart, supportive interventions without creating an intrusive nanny state? Can NGOs, foundations, educators and faith-based organizations do more? Is it possible to design a global prevention strategy?

Moderator:
Howard Soule, Senior Fellow, Milken Institute; Chief Science Officer, Prostate Cancer Foundation

Making it to 100 years old is no longer just a pipe dream; people are living longer now than ever before. What is the roadmap necessary to not only live longer but to also do so in good health, mind and spirit? Does it really boil down to diet and exercise? Yoga and meditation? Limiting the stress in our lives? We'll explore all the latest research on aging, medical advances to keep us younger and the day-to-day strategies you can start implementing right away to help you live longer.

Moderator:
Richard Merkin, CEO and Founder, Heritage Provider Network; Board Member, FasterCures

Improving the efficiency and quality of our health-care delivery system is vital to improving treatment outcomes, and it's just as critical to improving the cure enterprise. An efficient health-care system could free up funding for research and development. And by championing improved technologies such as electronic health records, we can serve the dual purposes of improving existing care programs while supporting the intense data needs of biomedical research. This panel will focus on developing successful models to reduce costs, making better use of data from the health-care system for research purposes, and encouraging biotechnology and pharmaceutical companies to focus on the reimbursement pathway well before the product is at the market's doorstep.

Moderator:
Wendy Selig, President and CEO, Melanoma Research Alliance

As many as two-thirds of cancer cases are linked to environmental factors such as ultraviolet light, tobacco, infectious agents and chemicals. Many of these can be avoided through lifestyle change, but this isn't the whole story. The environment interacts with our genomes, and the resulting genetic changes ultimately cause cancer. Cancer prevention will only be successful when individual behavior is combined with early medical intervention. What are some successful models, and what are the roadblocks to changing behavior? What are the exciting avenues of research towards cancer prevention agents, and what is the economic and regulatory environment for their development? What do we know about the genetic basis of risk, and how will this be applied for early intervention? Cancer screening has the potential for preventing some cancers, but there have been some controversies about benefits and risks. What are the challenges for population-based screening recommendations?

Moderator:
Aaron Task, Host, Daily Ticker, Yahoo Finance

Lost in the controversy surrounding national health-care reform is the fact that it's opened up new investment opportunities. Health-care providers, payors and the government are operating in a complex environment in which new participants will emerge, models will be reinvented, entrepreneurial opportunities will crop up, capital will be deployed and new business leaders will emerge. Amid these changing dynamics are ample value-creating possibilities for those who position themselves on the right side of the equation. Investment potential abounds in a range of sectors, including providers, managed care services, wellness and disease management, diagnostic technology and services, devices, IT services, staffing, and other companies serving the health-care sector. Our panel brings together thought leaders and stakeholders from various spheres of influence in the health-care community to explore how this transformation will evolve.

Moderator:
Paul Irving, Senior Managing Director and Chief Operating Officer, Milken Institute

Echoes of the baby boom will reverberate for decades to come. Approximately 1.5 billion people worldwide are age 50+, including more than 98 million Americans. We're just starting to grasp the policy implications of this powerful demographic shift, but what about the opportunities? Marketers have traditionally targeted a younger demographic, but all that could be about to change, given the spending power of boomer consumers. New products, services and markets are emerging to address the needs and aspirations of this population segment. What industries are geared to mature consumers? What businesses are poised for growth? What wants and needs has the market failed to fully understand? This panel of thought leaders will articulate a vision for the future that holds great promise for today's and tomorrow's mature adults - and for those savvy enough to appreciate the opportunity they represent.

Moderator:
Margaret Anderson, Executive Director, FasterCures / The Center for Accelerating Medical Solutions

Now that we've successfully decoded the human genome, how will we use that knowledge going forward? This session will explore the impact of genes on health and disease; our capacity to detect and act on clinically significant genomic information; the relevance of genetics to personalized medicine, genomics and public health; industry developments; and the relationships between genetic information and personal choice. Panelists will unravel the mysteries of the human genome and practical ways to use this information.